Low-Level Antimicrobials in the Medicinal Leech Select for Resistant Pathogens That Spread to Patients

Author:

Beka Lidia1,Fullmer Matthew S.1,Colston Sophie M.1,Nelson Michael C.1ORCID,Talagrand-Reboul Emilie23,Walker Paul4,Ford Bradley4,Whitaker Iain S.5,Lamy Brigitte267,Gogarten Johann Peter18,Graf Joerg18ORCID

Affiliation:

1. Department of Molecular and Cell Biology, University of Connecticut, Storrs, Connecticut, USA

2. Équipe Pathogènes Hydriques Santé Environnements, UMR 5569 HSM, Université de Montpellier, Montpellier, France

3. Département d’Hygiène Hospitalière, CHRU de Montpellier, Montpellier, France

4. Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA

5. Institute of Life Sciences, Swansea University College of Medicine, Swansea, Wales, United Kingdom

6. Laboratoire de Bactériologie, CHRU de Montpellier, Montpellier, France

7. INSERM U1065, C3M, Team 6, Nice, France

8. Institute for Systems Genomics, University of Connecticut, Storrs, Connecticut, USA

Abstract

ABSTRACT Fluoroquinolones (FQs) and ciprofloxacin (Cp) are important antimicrobials that pollute the environment in trace amounts. Although Cp has been recommended as prophylaxis for patients undergoing leech therapy to prevent infections by the leech gut symbiont Aeromonas , a puzzling rise in Cp-resistant (Cp r ) Aeromonas infections has been reported. We report on the effects of subtherapeutic FQ concentrations on bacteria in an environmental reservoir, the medicinal leech, and describe the presence of multiple antibiotic resistance mutations and a gain-of-function resistance gene. We link the rise of Cp r Aeromonas isolates to exposure of the leech microbiota to very low levels of Cp (0.01 to 0.04 µg/ml), <1/100 of the clinical resistance breakpoint for Aeromonas . Using competition experiments and comparative genomics of 37 strains, we determined the mechanisms of resistance in clinical and leech-derived Aeromonas isolates, traced their origin, and determined that the presence of merely 0.01 µg/ml Cp provides a strong competitive advantage for Cp r strains. Deep-sequencing the Cp r -conferring region of gyrA enabled tracing of the mutation-harboring Aeromonas population in archived gut samples, and an increase in the frequency of the Cp r -conferring mutation in 2011 coincides with the initial reports of Cp r Aeromonas infections in patients receiving leech therapy. IMPORTANCE The role of subtherapeutic antimicrobial contamination in selecting for resistant strains has received increasing attention and is an important clinical matter. This study describes the relationship of resistant bacteria from the medicinal leech, Hirudo verbana , with patient infections following leech therapy. While our results highlight the need for alternative antibiotic therapies, the rise of Cp r bacteria demonstrates the importance of restricting the exposure of animals to antibiotics approved for veterinary use. The shift to a more resistant community and the dispersion of Cp r -conferring mechanisms via mobile elements occurred in a natural setting due to the presence of very low levels of fluoroquinolones, revealing the challenges of controlling the spread of antibiotic-resistant bacteria and highlighting the importance of a holistic approach in the management of antibiotic use.

Funder

HHS | NIH | National Institute of General Medical Sciences

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3